157 related articles for article (PubMed ID: 38459154)
1. Transformation risk and associated survival outcome of marginal zone lymphoma: A nationwide study.
Sun X; Li H; Yang Y; Wu Y; Kang K; Liu Q; Luo R; Wang L; Zhao A; Niu T
Ann Hematol; 2024 Mar; ():. PubMed ID: 38459154
[TBL] [Abstract][Full Text] [Related]
2. Transformation to diffuse large B-cell lymphoma and its impact on survival in patients with marginal zone lymphoma: A population-based study.
Du Y; Wang Y; Li Q; Chang X; Shen K; Zhang H; Xiao M; Xing S
Int J Cancer; 2024 Mar; 154(6):969-978. PubMed ID: 37874120
[TBL] [Abstract][Full Text] [Related]
3. Transformation and survival in marginal zone lymphoma: a Finnish nationwide population-based study.
Kalashnikov I; Tanskanen T; Viisanen L; Malila N; Jyrkkiö S; Leppä S
Blood Cancer J; 2023 Apr; 13(1):62. PubMed ID: 37185610
[TBL] [Abstract][Full Text] [Related]
4. Deletion 20q12 is associated with histological transformation of nodal marginal zone lymphoma to diffuse large B-cell lymphoma.
Qian L; Soderquist C; Schrank-Hacker A; Strauser H; Dupoux V; Tang CN; Smith JR; Sun A; Majumdar S; Nguyen T; Widura S; Landsburg DJ; Schuster SJ; Baxter RHG; Bogusz AM
Am J Hematol; 2020 Mar; 95(3):238-244. PubMed ID: 31804739
[TBL] [Abstract][Full Text] [Related]
5. Clinical Characteristics, Treatment and Evolution of Splenic and Nodal Marginal Zone Lymphomas-Retrospective and Multicentric Analysis of Portuguese Centers.
Rodrigues CD; Peixeiro RP; Viegas D; Chorão P; Couto ME; Gaspar CL; Fernandes JP; Alves D; Ribeiro LA; de Vasconcelos M P; Tomé AL; Badior M; Coelho H; Príncipe F; Chacim S; da Silva MG; Coutinho R
Clin Lymphoma Myeloma Leuk; 2021 Nov; 21(11):e839-e844. PubMed ID: 34326035
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of Marginal Zone Lymphoma.
Cerhan JR; Habermann TM
Ann Lymphoma; 2021 Mar; 5():. PubMed ID: 33829216
[TBL] [Abstract][Full Text] [Related]
7. High-dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL-GITMO.
Avivi I; Arcaini L; Ferretti VV; Boumendil A; Finel H; Milone G; Zaja F; Liliana D; Musso M; Didier B; Bachy E; Wattad M; Nicolas-Virelizier E; Gramatzki M; Bourhis JH; Caillot D; Haenel A; Held G; Thieblemont C; Jindra P; Pohlreich D; Guilhot F; Kroschinsky F; Wahlin B; Scheid C; Ifrah N; Berthou C; Dreger P; Montoto S; Conconi A
Br J Haematol; 2018 Sep; 182(6):807-815. PubMed ID: 29984825
[TBL] [Abstract][Full Text] [Related]
8. A population-based study of transformed marginal zone lymphoma: identifying outcome-related characteristics.
Bult JAA; Huisman F; Zhong Y; Veltmaat N; Kluiver J; Tonino SH; Vermaat JSP; Chamuleau MED; Diepstra A; van den Berg A; Plattel WJ; Brink M; Nijland M
Blood Cancer J; 2023 Sep; 13(1):130. PubMed ID: 37658062
[TBL] [Abstract][Full Text] [Related]
9. Survival of patients with marginal zone lymphoma: analysis of the Surveillance, Epidemiology, and End Results database.
Olszewski AJ; Castillo JJ
Cancer; 2013 Feb; 119(3):629-38. PubMed ID: 22893605
[TBL] [Abstract][Full Text] [Related]
10. Marginal zone lymphoma: old, new, targeted, and epigenetic therapies.
Joshi M; Sheikh H; Abbi K; Long S; Sharma K; Tulchinsky M; Epner E
Ther Adv Hematol; 2012 Oct; 3(5):275-90. PubMed ID: 23616915
[TBL] [Abstract][Full Text] [Related]
11. Medical history, lifestyle, family history, and occupational risk factors for marginal zone lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.
Bracci PM; Benavente Y; Turner JJ; Paltiel O; Slager SL; Vajdic CM; Norman AD; Cerhan JR; Chiu BC; Becker N; Cocco P; Dogan A; Nieters A; Holly EA; Kane EV; Smedby KE; Maynadié M; Spinelli JJ; Roman E; Glimelius B; Wang SS; Sampson JN; Morton LM; de Sanjosé S
J Natl Cancer Inst Monogr; 2014 Aug; 2014(48):52-65. PubMed ID: 25174026
[TBL] [Abstract][Full Text] [Related]
12. Results of Upfront Therapy for Marginal Zone Lymphoma.
Ortega JL; Cabanillas F; Rivera N; Tirado-Gomez M; Hallman D; Pardo WI; Bruno M
Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):879-883. PubMed ID: 29042174
[TBL] [Abstract][Full Text] [Related]
13. Splenic Marginal Zone Lymphoma With Histological Transformation to Hodgkin's Lymphoma.
Veeraballi S; Mirza N; Khawar Z; Shaaban H
Cureus; 2022 Jul; 14(7):e26738. PubMed ID: 35967131
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome of 487 patients with early-stage extra-nodal marginal zone lymphoma.
Teckie S; Qi S; Chelius M; Lovie S; Hsu M; Noy A; Portlock C; Yahalom J
Ann Oncol; 2017 May; 28(5):1064-1069. PubMed ID: 28327924
[TBL] [Abstract][Full Text] [Related]
15. Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles.
Arcaini L; Paulli M; Boveri E; Vallisa D; Bernuzzi P; Orlandi E; Incardona P; Brusamolino E; Passamonti F; Burcheri S; Schena C; Pascutto C; Cavanna L; Magrini U; Lazzarino M
Cancer; 2004 Jan; 100(1):107-15. PubMed ID: 14692030
[TBL] [Abstract][Full Text] [Related]
16. Nodal monocytoid B-cell lymphoma (nodal marginal-zone B-cell lymphoma).
Nathwani BN; Drachenberg MR; Hernandez AM; Levine AM; Sheibani K
Semin Hematol; 1999 Apr; 36(2):128-38. PubMed ID: 10319381
[TBL] [Abstract][Full Text] [Related]
17. Transformation of marginal zone lymphoma (and association with other lymphomas).
Casulo C; Friedberg J
Best Pract Res Clin Haematol; 2017; 30(1-2):131-138. PubMed ID: 28288708
[TBL] [Abstract][Full Text] [Related]
18. Rare lymphomas in routine practice - Treatment and outcome in marginal zone lymphoma in the prospective German Tumour Registry Lymphatic Neoplasms.
Knauf W; Abenhardt W; Koenigsmann M; Maintz C; Sandner R; Zahn MO; Schnell R; Tech S; Kaiser-Osterhues A; Houet L; Marschner N;
Hematol Oncol; 2021 Aug; 39(3):313-325. PubMed ID: 33942348
[TBL] [Abstract][Full Text] [Related]
19. Contemporary management of nodal and primary splenic marginal zone lymphoma.
Leslie LA; Feldman TA; McNeill A; Timberg M; Iida H; Goy AH
Expert Rev Hematol; 2019 Dec; 12(12):1011-1022. PubMed ID: 31619091
[No Abstract] [Full Text] [Related]
20. Trends in incidence, therapy and outcome of localized nodal and extranodal marginal zone lymphomas: declining incidence and inferior outcome for gastrointestinal sites.
Kuper-Hommel MJ; van de Schans SA; Vreugdenhil G; van Krieken JH; Coebergh JW
Leuk Lymphoma; 2013 Sep; 54(9):1891-7. PubMed ID: 23302044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
